Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico; Federica Casiraghi; Fabiane Sônego; Marta Todeschini; Daniela Corna; Domenico Cerullo; Anna Pezzotta; Patricia Isnard‐Petit; Silvia Faravelli; Federico Forneris; Kader Thiam; Ariela Benigni; Giuseppe Remuzzi

doi:10.3389/fimmu.2024.1335998

Preprint2023

Bi-specific AutoAntigen-T cell Engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico, Federica Casiraghi, Fabiane Sônego, Marta Todeschini, Daniela Corna, Domenico Cerullo, Anna Pezzotta, Patricia Isnard‐Petit, Silvia Faravelli, Federico Forneris, Kader Thiam, Giuseppe Remuzzi, Ariela Benigni

Corrigendum2025

Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico, Federica Casiraghi, Fabiane Sônego, Marta Todeschini, Daniela Corna, Domenico Cerullo, Anna Pezzotta, Patricia Isnard‐Petit, Silvia Faravelli, Federico Forneris, Kader Thiam, Ariela Benigni, Giuseppe Remuzzi

Article2019

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

Alberto J. Espay, Joaquín A. Vizcarra, Luca Marsili, Anthony E. Lang, David K. Simon, Aristide Merola, Keith A. Josephs, Alfonso Fasano, Francesca Morgante, Rodolfo Savica, J. Timothy Greenamyre, Franca Cambi, Tritia R. Yamasaki, Caroline M. Tanner, Ziv Gan‐Or, Irene Litvan, Ignácio F. Mata, Cyrus P. Zabetian, Patrik Brundin, Hubert H. Fernandez, David G. Standaert, Marcelo Kauffman, Michael A. Schwarzschild, S. Pablo Sardi,

Article2024

Immunologic effects of B cell depletion on T cells in high-risk prostate cancer.

Sangwoo Shawn Kim, Jamillah Murtadha, Sayuri Miyauchi, Stephen Ryan, Jing Zhang, Emily Pittman, Karen Messer, Michael Karin, Christopher J. Kane, Ahmed Shabaik, Stephen B. Howell, Christina Jamieson, Andrew B. Sharabi

Editorial Material2015

Cytokine treatment in cancer immunotherapy

Michele Ardolino, Joy Hsu, David H Raulet

Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Abstract

Discussion(0)

Related publications

Bi-specific AutoAntigen-T cell Engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

Immunologic effects of B cell depletion on T cells in high-risk prostate cancer.

Cytokine treatment in cancer immunotherapy